LISATA THERAPEUTICS, INC. (LSTA) › Shareholders' EquityLISATA THERAPEUTICS, INC. (LSTA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2009: $57.83M2010: $86.49M2011: $80.13M2012: $32.82M2013: $62.03M2014: $58.07M2015: $23.28M2016: $4.07M2017: $50.19M2018: $37.45M2019: $20.55M2020: $32.24M2021: $92.00M2022: $66.32M2023: $47.89M2024: $29.32M2025: $14.60M$14.60M2009Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$14.60M-50.2%2024$29.32M-38.8%2023$47.89M-27.8%2022$66.32M-27.9%2021$92.00M+185.3%2020$32.24M+56.9%2019$20.55M-45.1%2018$37.45M-25.4%2017$50.19M+1134.4%2016$4.07M-82.5%2015$23.28M-59.9%2014$58.07M-6.4%2013$62.03M+89.0%2012$32.82M-59.0%2011$80.13M-7.3%2010$86.49M+49.5%2009$57.83M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share